Resources
About Us
Home Report
Store
Clinical Lab Automation Market
Clinical Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, Automated ELISA, Software), End User (Hospitals, Diagnostic Laboratories) – Global Forecast to 2031
Report ID:MRHC - 1041079 Pages: 209 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Clinical Lab Automation Market was valued at $2.22 billion in 2023. This market is expected to reach $4.01 billion by 2031, from an estimated $2.38 billion in 2024, at a CAGR of 7.8% during the forecast period 2024-2031.
Clinical Lab Automation Market Size & Forecast
The growth of this market can be attributed to several factors, including the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Moreover, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to offer growth opportunities for the players operating in the market.
Clinical Lab Automation Market Growth Drivers
Increasing Prevalence of Infectious & Chronic Diseases
The world is becoming increasingly connected, and infectious diseases are spreading rapidly due to cross-border travel. For instance, according to the World Health Organization (WHO), in 2021, an estimated 10.6 million people fell ill with tuberculosis (TB), an increase of 4.5% over 2020. In the same year, approximately 1.6 million people died from TB. The burden of Drug-resistant TB (DR-TB) also increased by 3% between 2020 and 2021, with 450,000 cases of Rifampicin-resistant TB (RR-TB) recorded in 2021. Globally, there were approximately 38.4 million people with HIV in 2021, a significant increase from 33.6 million in 2015. Of these, 36.7 million were adults, and 1.7 million were children (<15 years old). Diagnostic tests are crucial in the medical care of patients who have these diseases. Thus, the increasing prevalence of infectious & chronic diseases is expected to boost the demand for diagnostics, increasing the adoption of automated diagnostic devices and products.
Shortage of Skilled Professionals Leading to the Increased Use of Automated Systems
In recent years, laboratories and healthcare institutions have witnessed a major shortage of laboratory workers/professionals. According to the U.S. Bureau of Labor Statistics, the demand for clinical laboratory technicians and technologists is expected to grow by 5% from 2022 to 2032. This increasing demand is attributed to the aging workforce and the decreasing number of accredited training programs. To tackle this challenge, laboratories and hospitals can opt for automated devices such as automated PCR instruments and automated analyzers. The utilization of automated systems has increased since the COVID-19 pandemic. Market players are also focused on the development of automated systems for clinical laboratories.
Automation can significantly increase the efficiency of laboratories. For instance, Clear Labs, Inc. (U.S.), a private genomic testing company, offers a fully automated, next-generation sequencing platform for clinical diagnostics.
Click here to: Get Free Sample Pages of this Report
Clinical Lab Automation Market Trends
Increasing Applications of Next-Generation Sequencing Technology
Next-generation sequencing (NGS) technology has significantly reduced DNA sequencing costs. Moreover, it has revolutionized the field of genetic disease diagnostics with rapid, high-throughput, and cost-effective approaches. NGS can simultaneously analyze hundreds of genes, the whole exome, and the whole genome, enabling researchers to gain a deeper understanding of unknown species and complex diseases. This technology has recently gained much traction in diagnosing infectious diseases, immunological disorders, and hereditary disorders. It is also widely used for non-invasive prenatal diagnosis and therapeutic decision-making for somatic cancers.
The use of automated NGS instruments in clinical diagnosis offers several advantages. It enables shorter turnaround times, minimizes the need for manual intervention, provides fast and accurate results, and reduced the risk of contamination of nucleic acid crossover between sample runs.
Incorporation of Artificial Intelligence (AI) in Automated Instruments
Clinical laboratories are turning towards artificial intelligence (AI) to deal with incomplete and imprecise information. This integration of AI will help to facilitate workflows, enhance operational decision-making, and also reduce the number of working professionals. For instance, in September 2022, GE Healthcare (U.S.) launched a first ‘Made in India’ AI-powered Cath Lab – Optima IGS 320, which provides advanced cardiac care. This technology uses AI to automatically optimize image and dose parameters in real time, enabling clinicians to focus majorly on patients.
AI can also be used for quality control, predictive analytics, and data integration in laboratories, therefore increasing the demand for clinical lab automation instruments and driving the growth of the market.
Clinical Lab Automation Market Opportunity
Use of Clinical Lab Automation in Emerging Economies
The quality of healthcare in emerging economies and developing countries has increased due to use of automated instruments in clinical laboratories and hospitals even with limited resources, insufficient funding, and a shortage of skilled professionals. According to the Ministry of Health & Family Welfare of the Government of India, in 2021, the total number of tuberculosis patients were 19,33,381 as compared to 16,28,161 in 2020. For instance, in November 2022, MyLab Discovery Solutions Pvt Ltd. (India) received CDSCO, TB Expert Committee and ICMR approval for a Made in India TB Detection Kit that can detect tuberculosis using the automated MyLab Compact device that allows complete automated testing of multiple samples within 2 hours.
Such developments in developing and emerging economies will create opportunities for clinical lab automation instruments and services and drive the growth of the market.
Clinical Lab Automation Market Analysis: Key Findings
By Product: In 2024, the Systems Segment to Dominate the Clinical Lab Automation Market
Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2024, the systems segment is expected to account for the largest share of 84.3% of the clinical lab automation market. The large market share of this segment is attributed to the benefits of clinical lab automation systems, which facilitate procedures without manual intervention, enhancing laboratory testing capabilities. These systems mitigate repetitive tasks and errors, resulting in increased throughput and efficiency, ultimately improving the quality of test results.
By End User: In 2024, the Hospitals Laboratories Segment to Dominate the Clinical Lab Automation Market
Based on end users, the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2024, the hospital laboratories segment is expected to account for the largest share of 49.6% of the clinical lab automation market. Hospital laboratories automate clinical diagnostics to minimize human interventions in laboratory procedures. Automation improves the ordering, testing, and reporting of diagnostic tests in hospitals. Furthermore, the rising healthcare expenditures, the increasing prevalence of chronic diseases, increasing sample loads in hospitals, and improving healthcare infrastructure in developing countries drive the demand for lab automation systems. These factors contribute to the large market share of this segment.
Geographical Analysis
By Geography: North America to Dominate the Clinical Lab Automation Market in 2024
In 2024, North America is expected to account for the largest share of 40.4% of the clinical lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large market share of this region is primarily attributed to the high demand for automation due to the rising prevalence of various diseases, the growth in the healthcare sector, the increasing awareness regarding early disease diagnosis, the increasing healthcare expenditure, and the high adoption of advanced innovative diagnostic instruments.
Asia-Pacific is slated to register the highest CAGR of 9.0% in the clinical lab automation market during the forecast period. The growth of this market is primarily driven by the increasing investment by healthcare providers towards infrastructure improvement, the need to manage the growing burden of infectious diseases, the rising demand for clinical testing, supportive government initiatives to improve the accessibility to diagnostic services, and the need to establish more diagnostic laboratories.
Clinical Lab Automation Market: Key Companies
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.). As of 2023, Danaher Corporation (U.S.), Hamilton Company (U.S.), Abbott Laboratories (U.S.), and F. Hoffmann La-Roche AG (Switzerland) collectively hold a share of 44%-46% in the global clinical lab automation market.
Clinical Lab Automation Industry Overview: Latest Developments from Key Industry Players
-
In October 2023, Molecular Devices, LLC (U.S.) launched the CellXpress.ai automated cell culture system, which is an end-to-end machine learning-enabled solution that automates demanding feeding and has an integrated incubator, liquid handler, and imager.
-
In August 2023, Abbott Laboratories received FDA approval for the ALINITY h-Series, which includes an automated hematology analyzer that uses the multi-angle polarized scatter separation (MAPSS) technology to better identify blood cells.
- In February 2023, Hamilton Company launched the Microlab STAR V Automated Liquid Handling Platform. This system offers high-throughput capability and flexibility.
- In September 2021, Thermo Fisher Scientific, Inc. launched the Thermo Scientific Gallery Enzyme Master and Thermo Scientific Gallery Plus Enzyme Master analyzers that are fully automated and used for enzyme assay applications.
Clinical Lab Automation Market: Research Summary
|
Particulars |
Details |
|
Number of Pages |
209 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.8% |
|
Estimated Market Size (Value) |
$4.01 billion by 2031 |
|
Segments Covered |
By Product
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa. |
|
Key Companies |
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.) |
Key questions answered in the clinical lab automation market report:
This market study covers the market sizes & forecasts of the clinical lab automation market based on product, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the global clinical lab automation market at country levels.
The global clinical lab automation market is projected to reach $4.01 billion by 2031, at a CAGR of 7.8% during the forecast period.
Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2024, the systems segment is expected to account for the largest share of 84.3% of the market.
Based on end user, the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2024, the hospital laboratories segment is expected to account for the largest share of 49.6% of the market.
The growth of this market can be attributed to several factors, including the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Moreover, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to offer growth opportunities for the players operating in the market.
The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Emerging economies like Brazil and India are expected to witness significant demand for clinical lab automation systems and offer significant growth opportunities for market players in the coming years.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Regulatory Analysis
4.3.1. Overview
4.3.2. North America
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. Europe
4.3.4. Asia-Pacific
4.3.4.1. China
4.3.4.2. Japan
4.3.4.3. India
4.3.5. Latin America
4.3.6. Middle East
4.4. Pricing Analysis
4.5. Industry Trends
4.5.1. Shortage of Skilled Professionals Leading to the Increased Use of Automated Systems
4.5.2. Increasing Applications of Next-Generation Sequencing Technology
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Clinical Lab Automation Market Assessment–by Product
5.1. Overview
5.2. Systems
5.2.1. Automated Liquid Handling Systems
5.2.2. Automated ELISA Systems
5.2.3. Automated Nucleic Acid Purification Systems
5.2.4. Automated Microplate Readers
5.2.5. Other Systems
5.3. Clinical Lab Automation Software
6. Clinical Lab Automation Market Assessment–by End User
6.1. Overview
6.2. Hospital Laboratories
6.3. Diagnostic Laboratories
6.4. Other End Users
7. Clinical Lab Automation Market Assessment—by Geography
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia-Pacific
7.5. Latin America
7.6. Middle East & Africa
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Industry Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis (2023)
8.5.1. Danaher Corporation (U.S.)
8.5.2. Hamilton Company (U.S.)
8.5.3. Abbott Laboratories (U.S.)
9. Company Profiles
9.1. Danaher Corporation
9.2. Hamilton Company
9.3. Abbott Laboratories
9.4. F. Hoffmann-La Roche AG
9.5. Thermo Fisher Scientific, Inc.
9.6. Bio-Rad Laboratories, Inc.
9.7. Revvity, Inc. (Formerly Known as PerkinElmer, Inc.)
9.8. Agilent Technologies, Inc.
9.9. Waters Corporation
9.10. Tecan Group Ltd.
9.11. Siemens Healthineers Ag
9.12. Becton, Dickinson, and Company
9.13. Hudson Robotics, Inc.
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 HIV Prevalence, by Region, 2022
Table 2 Global: No. of Deaths Due to Cardiovascular Diseases, 1990–2021
Table 3 Key FDA Regulations for the Clinical Lab Automation Market
Table 4 Classification of Automated Clinical Laboratory Instruments
Table 5 Central Drugs Standard Control Organisation (CDSCO) Medical Device Classification
Table 6 India: Laws Regulating the Life Sciences Industry
Table 7 Clinical Lab Automation Instruments and Systems: Pricing Details
Table 8 Automated NGS Workstations: Pricing Details
Table 9 Global Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 10 Global Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 11 Global Clinical Lab Automation Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Automated Liquid Handling Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Type of Automated ELISA Systems
Table 14 Global Automated ELISA Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Automated Nucleic Acid Purification Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Recent Advancements in Microplate Reader Technology
Table 17 Global Automated Microplate Readers Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Other Clinical Lab Automation Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Clinical Lab Automation Software Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 21 Global Clinical Lab Automation Market for Hospital Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Clinical Lab Automation Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Clinical Lab Automation Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Clinical Lab Automation Market, by Country/Region, 2022–2031 (USD Million)
Table 25 North America: Clinical Lab Automation Market, by Country, 2022–2031 (USD Million)
Table 26 North America: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 27 North America: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 28 North America: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 29 U.S.: Key Macro & Micro Indicators
Table 30 U.S.: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 31 U.S.: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 32 U.S.: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 33 Canada: Key Macro & Micro Indicators
Table 34 Canada: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 35 Canada: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 36 Canada: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 37 Europe: Clinical Lab Automation Market, by Country/Region, 2022–2031 (USD Million)
Table 38 Europe: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 39 Europe: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 40 Europe: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 41 Germany: Key Macro & Micro Indicators
Table 42 Germany: Clinical Lab Automation Market, by Equipment, 2022–2031 (USD Million)
Table 43 Germany: Clinical Lab Automation Market Systems Market, by Type, 2022–2031 (USD Million)
Table 44 Germany: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 45 France: Key Macro & Indicators
Table 46 France: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 47 France: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 48 France: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 49 U.K.: Prevalence of Various Chronic Conditions
Table 50 U.K.: Key Macro & Micro Indicators
Table 51 U.K.: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 52 U.K.: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 53 U.K.: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 54 Italy: Key Macro & Micro Indicators
Table 55 Italy: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 56 Italy: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 57 Italy: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 58 Spain: Key Macro & Micro Indicators
Table 59 Spain: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 60 Spain: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 61 Spain: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 62 Rest of Europe: Percent of Elderly Population (2012 Vs 2021 Vs 2022)
Table 63 Rest of Europe: Cancer Statistics (2020 Vs. 2030)
Table 64 Rest of Europe: Diabetes Statistics (2021 Vs. 2030) (In Thousands)
Table 65 Rest of Europe: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 66 Rest of Europe: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 67 Rest of Europe: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 68 Asia-Pacific: Clinical Lab Automation Market, by Country, 2022–2031 (USD Million)
Table 69 Asia-Pacific: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 70 Asia-Pacific: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 71 Asia-Pacific: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 72 China: Key Macro & Micro Indicators
Table 73 China: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 74 China: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 75 China: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 76 Japan: Key Macro & Micro Indicators
Table 77 Japan: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 78 Japan: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 79 Japan: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 80 India: Key Macro & Micro Indicators
Table 81 India: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 82 India: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 83 India: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 84 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 85 RoAPAC: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 86 Rest of Asia-Pacific: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 87 Rest of Asia-Pacific: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 88 Rest of Asia-Pacific: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 89 Latin America: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 90 Latin America: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 91 Latin America: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 92 Middle East & Africa: Clinical Lab Automation Market, by Product, 2022–2031 (USD Million)
Table 93 Middle East & Africa: Clinical Lab Automation Systems Market, by Type, 2022–2031 (USD Million)
Table 94 Middle East & Africa: Clinical Lab Automation Market, by End User, 2022–2031 (USD Million)
Table 95 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Clinical Lab Automation Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 Global Clinical Lab Automation Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 9 Clinical Lab Automation Market Size, by Geography
Figure 10 Global Clinical Lab Automation Market: Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024–2031)
Figure 11 Population Aged 65 Years or Over, by Region, 2020 Vs. 2030 (In Million)
Figure 12 Global: Estimated Number of New Cancer Cases, 2020–2040 (In Million)
Figure 13 Global Prevalence of Diabetes, 2000–2045 (In Million)
Figure 14 Global: Total Number of Accredited Testing Laboratories, 2016–2020
Figure 15 Incidence of Tuberculosis, by Region, 2021 (In Million)
Figure 16 EU Regulatory Pathway – IVDR 2017/746
Figure 17 China: Medical Devices Classification and Pre-Market Requirements for IVD Devices
Figure 18 Porter's Five Forces Analysis
Figure 19 Global Clinical Lab Automation Market, by Product, 2024 Vs 2031 (USD Million)
Figure 20 Advantages of Using Automated ELISA Systems
Figure 21 Global Clinical Lab Automation Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 22 Global Clinical Lab Automation Market, by Country/Region, 2024 Vs. 2031 (USD Million)
Figure 23 North America: Clinical Lab Automation Market Snapshot
Figure 24 Geriatric Population in Canada (2019–2050)
Figure 25 Estimated Number of New Cancer Cases (2020–2040)
Figure 26 Europe: Clinical Lab Automation Market Snapshot
Figure 27 U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population, 2017–2021
Figure 28 Italy: Percentage of The Population Aged 65 & Above, 2010–2021
Figure 29 Spain: Number of People Living with HIV (2010-2021)
Figure 30 Asia-Pacific: Clinical Lab Automation Market Snapshot
Figure 31 China: Number of New Cancer Cases (2020-2040) (In Million)
Figure 32 Japan: Share of Geriatric Population in Total Population (65 and Over)
Figure 33 Brazil: Number of People with Diabetes (In Thousands)
Figure 34 Key Growth Strategies Adopted by Leading Players 2021-2024
Figure 35 Clinical Lab Automation Market: Competitive Benchmarking by Product Type
Figure 36 Clinical Lab Automation Market: Competitive Benchmarking, by Region
Figure 37 Competitive Dashboard: Clinical Lab Automation Market
Figure 38 Global Clinical Lab Automation Market Share Analysis, by Key Players (2023)
Figure 39 Danaher Corporation: Financial Overview (2023)
Figure 40 Abbott Laboratories: Financial Overview (2023)
Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2023)
Figure 42 Thermo Fisher Scientific, Inc.: Financial Overview (2023)
Figure 43 Bio-Rad Laboratories, Inc.: Financial Overview (2023)
Figure 44 PerkinElmer, Inc.: Financial Overview (2023)
Figure 45 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 46 Waters Corporation: Financial Overview (2023)
Figure 47 Tecan Group Ltd.: Financial Overview (2023)
Figure 48 Siemens Healthineers AG: Financial Overview (2023)
Figure 49 Becton, Dickinson, and Company: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Clinical Trials Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
eClinical Solutions Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
Clinical Trial Supplies Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Feb-2024
Lab Automation Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
NGS Automation Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Jun-2022
